Atlas Trials

Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer

Clinical trial NCT07406594 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07406594
Sponsor
University of Vermont Medical Center
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerHER-2 Positive Breast Cancer
Start date
2027-10-01
Primary completion
2031-10-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.